Allergan Dodges Class Action Over Pricey Eye Drops
A Missouri federal judge threw out a putative class action alleging Allergan USA Inc. overcharged consumers for chronic dry eye treatment Restasis by filling dispensers with pricey excess medicine, holding Tuesday...To view the full article, register now.
Already a subscriber? Click here to view full article